Effectiveness and safety of direct-acting antiviral therapies in chronic hepatitis C infections patients with cirrhosis in Turkey

Tabak, F.Çuvalcı, Nefise Ö.Kurtaran, B.Önlen, YusufSarı, Nagehan DidemKaya, ŞükrüYamazhan, Tansu2020-05-012020-05-0120180168-82781600-0641https://doi.org/10.1016/S0168-8278(18)30814-6https://hdl.handle.net/20.500.12684/5784International Liver Congress (ILC) -- APR 11-15, 2018 -- Paris, FRANCEWOS: 000461068601206…en10.1016/S0168-8278(18)30814-6info:eu-repo/semantics/closedAccessEffectiveness and safety of direct-acting antiviral therapies in chronic hepatitis C infections patients with cirrhosis in TurkeyConference Object68S297S298WOS:000461068601206Q1